Loading…
Sight Sciences, Inc. is projected to rise to $7.13 by 2027, a +46% move from its current price of $4.87. SGHT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.69 | $4.87 | $5.06 | +0.04% |
| May 30 | $4.62 | $4.87 | $5.14 | +0.08% |
| May 31 | $4.57 | $4.88 | $5.21 | +0.12% |
| Jun 1 | $4.52 | $4.88 | $5.26 | +0.15% |
| Jun 2 | $4.48 | $4.88 | $5.31 | +0.19% |
| Jun 3 | $4.45 | $4.88 | $5.36 | +0.23% |
| Jun 4 | $4.42 | $4.88 | $5.40 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.42 | $4.88 | $5.40 | +0.27% |
| Week 2 | $4.25 | $4.90 | $5.64 | +0.54% |
| Week 3 | $4.13 | $4.91 | $5.84 | +0.82% |
| Week 4 | $4.03 | $4.92 | $6.02 | +1.09% |
| Week 5 | $3.94 | $4.94 | $6.18 | +1.36% |
| Week 6 | $3.87 | $4.95 | $6.33 | +1.64% |
| Week 7 | $3.80 | $4.96 | $6.48 | +1.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sight Sciences, Inc. is an ophthalmic medical device company focused on developing and commercializing surgical and nonsurgical technologies for the treatment of eye diseases in the United States.
The company operates in two segments, Surgical Glaucoma and Dry Eye, and offers a portfolio including OMNI, a surgical system family of products (OMNI Ergo for catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma) and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. It also provides SION, a bladeless and manually operated device, and TearCare, a dry eye device designed to melt and restore gland functionality when used with manual expression of the meibomian glands.
It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Sight Sciences, Inc. (SGHT) currently trades at $5.03 with a market capitalization of $273.68M. Its market rank is 3606. The stock’s near-term outlook is framed by a forecast of rising averages in the years ahead, starting from a 2026 avg of $5.03 and climbing toward longer-horizon values.
Forecasts indicate upside potential, with the 2026 avg price at $5.03 increasing to $8.17 by 2030 and then rising further to $28.97 by 2050. The projection for 2050 also shows a max price of $62.95, underscoring a bullish long-run view.
A major floor 35.5% below — a decisive break under it would weaken the trend.
The nearest floor, 21.4% below — buyers have tended to step in here.
The nearest ceiling, 10.5% above — a clean break opens room to run.
A major ceiling 32.9% above — clearing it would confirm fresh momentum.
Key SGHT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SGHT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.98 | Sell | $4.95 | Sell |
| MA 10 | $4.95 | Sell | $4.93 | Sell |
| MA 20 | $4.79 | Buy | $4.79 | Buy |
| MA 50 | $4.23 | Buy | $4.64 | Buy |
| MA 100 | $4.99 | Sell | $4.86 | Buy |
| MA 200 | $5.23 | Sell | $4.93 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.84 | Neutral |
| Stoch RSI (14) | 4.78 | Buy |
| CCI (20) | 15.23 | Neutral |
| Williams %R (14) | -77.27 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -9.48 | Sell |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 22.73 | Neutral |
| TRIX (15) | 0.80 | Buy |
| Awesome (5,34) | 0.50 | Buy |
| Ultimate (7,14,28) | 50.84 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 5.02 | Sell |
| ADX (14) | 17.34 | Neutral |
| ATR (14) | 0.17 | Info |
Near-term technical picture shows a NEUTRAL sentiment with RSI14 at 60.
The moving-average backdrop features SMA50 at $4.18 and SMA200 at $5.22, with a defined support at $3.69 and resistance at $5.38. The 30-day trading range spans from $3.86 to $6.55, outlining the near-term price ceiling and floor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.45 | $4.87 | $7.11 | 0% | Neutral | |
| $5.44 | $7.13 | $10.01 | +46% | Bullish | |
| $5.13 | $7.00 | $10.31 | +44% | Bullish | |
| $4.97 | $7.00 | $10.69 | +44% | Bullish | |
| $5.43 | $7.89 | $12.43 | +62% | Bullish | |
| $4.90 | $7.31 | $11.83 | +50% | Bullish | |
| $5.77 | $8.85 | $14.66 | +82% | Bullish | |
| $7.31 | $11.48 | $19.44 | +136% | Bullish | |
| $7.16 | $11.51 | $19.89 | +136% | Bullish | |
| $7.10 | $11.68 | $20.55 | +140% | Bullish | |
| $9.50 | $17.38 | $33.02 | +257% | Bullish | |
| $12.71 | $28.25 | $59.90 | +480% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.45 | $4.87 | $5.76 | +0.00% |
| June 2026 | $4.28 | $5.07 | $6.18 | +4.10% |
| July 2026 | $4.21 | $5.04 | $6.26 | -0.49% |
| August 2026 | $4.06 | $4.91 | $6.18 | -2.68% |
| September 2026 | $4.21 | $5.13 | $6.53 | +4.48% |
| October 2026 | $4.43 | $5.43 | $6.99 | +5.92% |
| November 2026 | $4.38 | $5.41 | $7.02 | -0.52% |
| December 2026 | $4.37 | $5.43 | $7.11 | +0.39% |
Click any year to see its month-by-month SGHT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SGHT is projected to trade between $3.45 and $7.11, averaging $4.87 — a potential gain of 0% from today's $4.87. A consolidation phase looks the most probable path here.
Sight Sciences, Inc.'s 2027 outlook centres on $7.13, within a $5.44 to $10.01 range. That is up +46% on the projected 2026 average. That marks a +46% change versus current levels. Momentum favours further upside here.
By 2028, SGHT could reach as high as $10.31, with a base case around $7.00 and support toward $5.13 — roughly +44% from $4.87. Buyers look set to stay in control over this stretch.
Expect SGHT to range from $4.97 to $10.69 through 2029. The $7.00 average target implies a +44% move from current prices. That is up 0% on the projected 2028 average. Momentum favours further upside here.
The SGHT price prediction for 2030 points to an average of $7.89 (low $5.43, high $12.43) — a potential gain of +62% on today's $4.87. Buyers look set to stay in control over this stretch.
In 2031, SGHT is projected to trade between $4.90 and $11.83, averaging $7.31 — a potential gain of +50% from today's $4.87. That is -7% versus the projected 2030 average. Momentum favours further upside here.
Sight Sciences, Inc.'s 2032 outlook centres on $8.85, within a $5.77 to $14.66 range. That is up +21% on the projected 2031 average. That marks a +82% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, SGHT could reach as high as $19.44, with a base case around $11.48 and support toward $7.31 — roughly +136% from $4.87. Momentum favours further upside here.
Expect SGHT to range from $7.16 to $19.89 through 2034. The $11.51 average target implies a +136% move from current prices. That is up 0% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The SGHT price prediction for 2035 points to an average of $11.68 (low $7.10, high $20.55) — a potential gain of +140% on today's $4.87. Momentum favours further upside here.
In 2040, SGHT is projected to trade between $9.50 and $33.02, averaging $17.38 — a potential gain of +257% from today's $4.87. That is up +49% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Sight Sciences, Inc.'s 2050 outlook centres on $28.25, within a $12.71 to $59.90 range. That is up +63% on the projected 2040 average. That marks a +480% change versus current levels. Momentum favours further upside here.
Investing $1,000 in SGHT today (≈ 205.338809 SGHT) could be worth
$5,801.1
+$4,801.1 (+480%) by 2050 · US Dollar
Based on the average projected SGHT price of $28.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SGHTwould be worth at today's price.
$1,000 invested in SGHT on May 27, 2025 (≈ 290.69767 SGHT) would be worth
$1,415.7
+$415.7 (+41.6%) today · 1.42× · US Dollar
Based on a SGHT entry price of $3.44 vs. today's $4.87.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.86 | $1,002.06 | +0.2% |
| 1 month ago | $4.32 | $1,127.31 | +12.7% |
| 3 months ago | $5.32 | $915.41 | -8.5% |
| 6 months ago | $8.36 | $582.54 | -41.7% |
| 1 year ago | $3.44 | $1,415.7 | +41.6% |
| All time (4.9y) ago | $33.5 | $145.37 | -85.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SGHT forecast.
Our base-case forecast reaches $9.70 around 2033.
Implied market cap at $9.70: $527.78M
The multi-year outlook projects a bullish trajectory across the horizon. In 2026 the avg is $5.03 with a min of $3.45 and a max of $7.46 and a neutral tone. By 2027 the avg rises to $7.45 (ROI 48.1%) and remains bullish through 2029 with 2028 at $7.23 (ROI 43.7%) and 2029 at $7.26 (ROI 44.4%).
The 2030 forecast shows an avg of $8.17 with a 62.5% ROI as sentiment stays BULLISH.
Beyond 2030, the path stays upward with 2032 avg $9.14 (ROI 81.6%), 2033 avg $11.98 (ROI 138.2%), 2034 avg $11.80 (ROI 134.5%), and 2035 avg $12.03 (ROI 139.1%). Max prices in these years rise toward $20.65 (2033) and $21.57 (2035). In the longer horizon, 2040 carries an avg of $17.74 (ROI 252.7%) and max $34.42, while 2050 shows an avg of $28.97 (ROI 475.9%) with a max of $62.95, all under a bullish lens.
These figures illustrate meaningful upside potential but remain estimates, not guarantees, and should be considered with inherent market risk.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $8.17 with a min of $5.54 and a max of $13.07; the implied ROI is 62.5% and the sentiment is BULLISH.
The forecast displays bullish sentiment from 2027 onward and rising averages, with 2027 avg $7.45, 2030 avg $8.17, 2040 avg $17.74, and 2050 avg $28.97, plus a max price of $62.95 by 2050 and ROI as high as 475.9%. These imply upside potential but are not guarantees.
Yes. The forecast max reaches $20.65 in 2033, $20.75 in 2034, and $21.57 in 2035, with later years showing higher max values such as $34.42 in 2040 and $62.95 in 2050.
The current price is $5.03.
The 30-day range is from $3.86 to $6.55.
Sight Sciences, Inc. Community Discussion
0Share your Sight Sciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.